Skip to main content
PMC home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2019 Dec 11;76(7):952–960. doi: 10.1093/ps/76.7.952

Atypical Escherichia coli strains and their association with poult enteritis and mortality syndrome

FW Edens 1, CR Parkhurst 1, MA Qureshi 1, IA Casas 1, GB Havenstein 1
PMCID: PMC7107179  PMID: 9200230

Abstract

To date, no definitive etiology has been described for Poult Enteritis and Mortality Syndrome (PEMS). However, two atypical Escherichia coli colony types are isolated consistently from moribund and dead poults afflicted with PEMS. To test the infectivity of these E. coli strains, poults were placed into floor pens in three isolation treatment rooms: 1) Control: no bacterial challenge, 2) E. coli colony Types 1 or 2 posthatch oral challenge: 10(8) cfu/per poult at 1 d, and 3) E. coli colony Types 1 or 2 posthatch oral challenge: 10(8) cfu/per poult at 6 d. Daily intramuscular injections of cyclophosphamide (100 micrograms per poult) from 1 to 5 d posthatch were given to half of the poults in each treatment. Atypical E. coli challenge caused BW depression, and cyclophosphamide treatment exacerbated the response. All E. coli-challenged poults developed diarrhea similar to PEMS. Mortality was increased by both atypical E. coli colony types, but at 21 d E. coli colony Type 2 caused greater mortality than colony Type 1. With cyclophosphamide treatment, mortality was exacerbated with both colony types, but colony Type 2 at 1 d caused the greatest mortality. Ultrastructural damage to ileum epithelium cell microvilli and subcellular organelles indicated that part of the BW depression could be attributed to malabsorption of nutrients. It was concluded that the atypical E. coli colony Types 1 and 2 play a significant role in the PEMS disease.

REFERENCES

  1. Barnes, H. J. and J. S. Guy, 1995. Spiking mortality of turkeys (SMT) and related disorders: an update, Pages 16–21 in: Proceedings 19th Annual North Carolina Turkey Industry Days Conference, North Carolina State University, Raleigh, NC.
  2. Barnes, H. J., J. S. Guy, T. P. Brown, and F. W. Edens, 1996. Poult enteritis and mortality syndrome (“spiking mortality of turkeys”) and related disorders—An update and overview. Newsletter, College of Veterinary Medicine and College of Agriculture and Life Sciences, North Carolina State University, October 29, 1996:1–11.
  3. Beisel W.R. Metabolic effect of infection. Prog. Food Nutri. Sci. 1984;8:43–75. [PubMed] [Google Scholar]
  4. Brown, T. P., 1995. Spiking mortality: Pathology, performance, and prevention. Pages 34–44 in: Proceedings 6th Annual Eli Lilly Technical Seminar. Vol. 6. Indianapolis, IN.
  5. Glick B. Morphological changes and humoral immunity in cyclophosphamide-treated chicks. Transplantation. 1971;11:433–439. doi: 10.1097/00007890-197105000-00001. [DOI] [PubMed] [Google Scholar]
  6. Glick B. The bursa of Fabricius and immunoglobulin synthesis. Int. Rev. Cytol. 1977;48:345–402. doi: 10.1016/s0074-7696(08)61749-0. [DOI] [PubMed] [Google Scholar]
  7. Larsen C.T., Domermuth C.H., Sponenberg D.P., Gross W.B. Colibacillosis of turkeys exacerbated by hemorrhagic enteritis virus. Laboratory studies. Avian Dis. 1985;29:729–732. [PubMed] [Google Scholar]
  8. Leitner G., Heller E.D. Colonization of Escherichia coli in young turkeys and chickens. Avian Dis. 1992;36:211–220. [PubMed] [Google Scholar]
  9. Lerman S.P., Weidanz W.D. Selective suppression of humoral immunity. The effect of cyclophosphamide on the ontogeny of the humoral immune response in chickens. J. Immunol. 1970;105:614–619. [PubMed] [Google Scholar]
  10. Newberry L.A., Skeeles J.K., Kreider D.L., Beasley J.N., Story J.D., McNew R.W., Berridge B.R. Use of virulent hemorrhagic enteritis virus for the induction of colibacillosis in turkeys. Avian Dis. 1993;37:1–5. [PubMed] [Google Scholar]
  11. Qureshi M.A., Edens F.W., Havenstein G.B. Immune system dysfunction during exposure to poult enteritis and mortality syndrome agents. Poultry Sci. 1996;76:564–569. doi: 10.1093/ps/76.4.564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rennie M.J. Muscle protein turnover and wasting due to injury and disease. Br. Med. Bull. 1985;41:257–264. doi: 10.1093/oxfordjournals.bmb.a072060. [DOI] [PubMed] [Google Scholar]
  13. SAS Institute . SAS® User's Guide: Statistics. Version 5 Edition. SAS Institute Inc.; Cary, NC: 1985. [Google Scholar]
  14. Sharma J.M. Embryo vaccination of specific pathogen free chickens with infectious bursal disease virus and tissue distribution of the vaccine virus and protection of hatched chicks against the disease. Avian Dis. 1986;30:776–780. [PubMed] [Google Scholar]
  15. Sponenberg D.P., Domermuth C.H., Larsen C.T. Field outbreaks of colibacillosis of turkeys associated with hemorrhagic enteritis virus. Avian Dis. 1985;29:823–842. [PubMed] [Google Scholar]
  16. Tian S., Baracos V.E. Effect of Escherichia coli infection on growth and protein metabolism in broiler chicks (Gallus domesticus) Comp. Biochem Physiol. 1989;94A:323–331. doi: 10.1016/0300-9629(89)90554-9. [DOI] [PubMed] [Google Scholar]
  17. van den Hurk J.V., Allan B.J., Riddell C., Watts T., Potter A.A. Effect of infection with hemorrhagic enteritis virus on susceptibility of turkeys to Escherichia coli. Avian Dis. 1994;38:708–716. [PubMed] [Google Scholar]
  18. Williams C.J., Womack C.L., Murray D.L., Miles A.M., Gildersleeve R.P. Commercial broiler studies of Marek's disease vaccination in ovo. Poultry Sci. 1992;71(Suppl.1):185. (Abstr.) [Google Scholar]

Articles from Poultry Science are provided here courtesy of Elsevier

RESOURCES